Arrhythmias & electrophysiology

Temporal Trends in Atrial Fibrillation Ablation in the Elderly: Incidence of Major Adverse Cardiovascular Events (MACE) and Recurrence Rates

JACC Clin ElectrophysiolPublished Retrospective cohort study

Main finding · 5-year MACE, last time periodResult — go to the resultHazard ratio 1.52 95% CI 1.26–1.83

Authors' conclusion

AF ablation use in the elderly has significantly increased over time. A notable decrease in MACE was evident across all age cohorts, with a particularly pronounced trend observed among the elderly population. Age was not an independent predictor of the composite endpoint.

Study context

Population
Individuals undergoing first-time atrial fibrillation (AF) ablation, Denmark, 2001–2020
Exposure
First-time AF ablation by age group (<60, 60-74, ≥75 years) across 4 consecutive 5-year intervals
Outcome
MACE; composite of AF-related hospitalizations, repeat AF ablation or use of AADs
Follow-up
5-year MACE; 1-year composite
Methodological detailsnationwide Danish administrative registers
  • Nationwide Danish administrative registers

Main finding

5-year MACE, last time period

Hazard ratio

1.52

95% CI 1.26–1.83

≥75
HR 1.52 (95% CI 1.26–1.83)

As reported in the abstract

Elderly undergoing AF ablation increased significantly, from 0 in 2001
9% in 2020
5-year MACE incidence in elderly decreased from
61.9% (95% CI: 41.1%-82.7%)
5-year MACE incidence in elderly decreased to
38.1% (95% CI: 31.9%-44.2%)

Observational data: associations, not effects.

Further findings

Composite of AF-related hospitalizations, repeat AF ablation or AAD use · 1 year

Composite outcome varied from 35.6% to 52.0%; age not a consistent predictor

Original publication

Temporal Trends in Atrial Fibrillation Ablation in the Elderly: Incidence of MACE and Recurrence Rates. JACC Clin Electrophysiol. Published 13 November 2024. doi:10.1016/j.jacep.2024.09.024

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.